Heart Disease and Stroke Statistics—2012 Update

Q: What is the clinical evidence from this study?

Study design: Review. Population: Heart Disease and Stroke.

Véronique L. Roger; Alan S. Go; Donald M. Lloyd‐Jones; Emelia J. Benjamin; Jarett D. Berry; William B. Borden; Dawn M. Bravata; Shifan Dai; Earl S. Ford; Caroline S. Fox; Heather J. Fullerton; Cathleen Gillespie; Susan M. Hailpern; John A. Heit; Virginia J. Howard; Brett Kissela; Steven J. Kittner; Daniel T. Lackland; Judith H. Lichtman; Lynda D. Lisabeth; Diane M. Makuc; Gregory M. Marcus; Ariane Marelli; David B. Matchar; Claudia S. Moy; Dariush Mozaffarian; Michael E. Mussolino; Graham Nichol; Nina P. Paynter; Elsayed Z. Soliman; Paul D. Sorlie; Nona Sotoodehnia; Tanya N. Turan; Salim S. Virani; Nathan D. Wong; Daniel Woo; Melanie B. Turner

doi:10.1161/cir.0b013e31823ac046

Key result

The Heart Disease and Stroke Statistics 2012 Update provides a comprehensive overview of cardiovascular diseases, stroke, and related risk factors.

Key Points

To compile and report the most recent surveillance data on cardiovascular diseases, stroke, and associated risk factors to track national progress toward cardiovascular health metrics.
Synthesized vital statistics, morbidity data, and clinical outcomes compiled from federal health agencies, national health surveys, and epidemiological cohort studies.
Categorized disease burden across subclinical atherosclerosis, coronary heart disease, stroke, hypertension, congenital defects, and cardiomyopathy.
Presents comprehensive epidemiological trends across demographic strata, identifying persistent disparities in morbidity, mortality, and risk factor prevalence.
Benchmarks population-level statistics against the American Heart Association 2020 Impact Goals for cardiovascular health promotion and disease reduction.

PICO

P

Population

Heart Disease and Stroke

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Provides the 2012 update on heart disease and stroke statistics from the American Heart Association.

Abstract

Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e3 1. About These Statistics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e7 2. American Heart Association's 2020 Impact Goals. . . . . . . . . . . . . . . . .e10 3. Cardiovascular Diseases . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . .e21 4. Subclinical Atherosclerosis . . . . . . . . . . . . . . . . . . . . .e45 5. Coronary Heart Disease, Acute Coronary Syndrome, and Angina Pectoris . . . . . . . . .e54 6. Stroke (Cerebrovascular Disease) . . . . . . . . . . . . . . . . . . . . . . . . . . . .e68 7. High Blood Pressure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .e88 8. Congenital Cardiovascular Defects . . . . . . . . . . . . . . . . . . . . . . . . . . . .e97 9. Cardiomyopathy and Heart Failure . . . . . . . . . . . . . . . . . . . . . . . . . . . .e102 10. Disorders …

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Roger et al. (2011) conducted a review in Heart Disease and Stroke. The Heart Disease and Stroke Statistics 2012 Update provides a comprehensive overview of cardiovascular diseases, stroke, and related risk factors.

synapsesocial.com/papers/6a7c9613704b28adc84c7333 https://doi.org/10.1161/cir.0b013e31823ac046

View Full Paper

Ask AI

Bookmark

Share

Heart Disease and Stroke Statistics—2012 Update

Key Points

PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Heart Disease and Stroke Statistics—2012 Update

Key Points

PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading